Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.8201
-0.0199 (-2.37%)
At close: Jun 18, 2026, 4:00 PM EDT
0.8300
+0.0099 (1.21%)
After-hours: Jun 18, 2026, 6:07 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $25.54 million as of June 18, 2026. Its market cap has increased by 43.01% in one year.
Market Cap
25.54M
Enterprise Value
10.53M
1-Year Change
43.01%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $25.54M, a decrease of -85.19%. That is a compound annual growth rate of -30.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 25.54M | 136.63% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 27.50M |
| IGC Pharma | 27.16M |
| Kyntra Bio | 27.12M |
| Barinthus Biotherapeutics | 27.05M |
| Evaxion | 25.44M |
| BriaCell Therapeutics | 25.30M |
| Polyrizon | 25.12M |
| Skye Bioscience | 24.85M |